-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Tmn0T7bVLmOIhVl3SEZSkqt+eZLAp7X0+SaGWfVLnRf4BFlfqhTiIMmmdip2nm1f
 9gQhK6bL5UaZNI1RNdOENw==

<SEC-DOCUMENT>0001104659-07-007521.txt : 20070206
<SEC-HEADER>0001104659-07-007521.hdr.sgml : 20070206
<ACCEPTANCE-DATETIME>20070206140251
ACCESSION NUMBER:		0001104659-07-007521
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20070202
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070206
DATE AS OF CHANGE:		20070206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		07583799

	BUSINESS ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a07-3636_18k.htm
<DESCRIPTION>8-K
<TEXT>
<html>

<head>







</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">
 <div style="border:none;border-top:double windowtext 6.0pt;padding:0pt 0pt 0pt 0pt;"> <p style="border:none;margin:0pt 0pt .0001pt;padding:0pt;"><a name="scotch"></a><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p> </div>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED
STATES</font></b></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES
AND EXCHANGE COMMISSION</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM
8-K</font></b></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT
REPORT</font></b></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">PURSUANT
TO SECTION 13 OR 15(d) OF THE</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">SECURITIES
EXCHANGE ACT OF 1934</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report
(Date of earliest event reported): <b>February
2, 2007</b></font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-KEY
INTERNATIONAL, INC.</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact Name of Registrant as Specified in Its Charter)</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;letter-spacing:-.15pt;">(State or Other Jurisdiction</font> <font style="letter-spacing:-.15pt;">of
Incorporation)</font></font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="font-size:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><!-- SET mrlNoTableShading --><b>1-13463</b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File
  Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(IRS Employer
  Identification No.)</font></p>
  </td>
 </tr>
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349
  Highway 138, Building D, Suite B, Wall, NJ </font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">07719</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of
  Principal Executive Offices)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip Code)</font></p>
  </td>
 </tr>
 <tr>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt .7pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="48%" valign="top" style="padding:0pt .7pt 0pt .7pt;width:48.8%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0pt .7pt 0pt .7pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">732-359-1100</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0pt .7pt 0pt .7pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s
  Telephone Number, Including Area Code)</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160; Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160; Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 13.5pt;text-indent:-13.5pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160; Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 13.5pt;text-indent:-13.5pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160; Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>


 <div style="border:none;border-bottom:double windowtext 6.0pt;padding:0pt 0pt 0pt 0pt;"> <p style="border:none;margin:0pt 0pt .0001pt;padding:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p> </div>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\Fc\3722512350_P66499CHE_1677739\3636-1-ba.htm',USER='jmsproofassembler',CD='Feb  6 22:05 2007' -->



<br clear="all" style="page-break-before:always;">
<div>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 8.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other Events.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attached hereto as
Exhibit&nbsp;99.1 is the registrant&#146;s Press Release, issued January 31, 2007,
relating to the offer by the Company to acquire all of the outstanding common
shares of Comnetix.</font></p>

<p style="margin-left:0pt;margin-right:0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 9.01.
&nbsp;&nbsp;FINANCIAL STATEMENTS AND EXHIBITS.</font></b></p>

<p style="margin-left:48.0pt;margin-right:0pt;text-indent:-30.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibits.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="14%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:14.74%;">
  <p align="left" style="font-size:8.0pt;font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:left;"><!-- SET mrlNoTableShading -->Exhibit&nbsp;Number</p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="82%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:82.88%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Description</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="14%" valign="bottom" style="border:none;padding:0pt .7pt 0pt 0pt;width:14.74%;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="82%" valign="bottom" style="border:none;padding:0pt .7pt 0pt 0pt;width:82.88%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="14%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:14.74%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="2%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="82%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:82.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press Release, issued February 2, 2007, relating to
  the offer by the Company to acquire all of the outstanding common shares of
  Comnetix.</font></p>
  </td>
 </tr>
</table>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


 <p align="center" style="font-size:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">2</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\svasudea\07-3636-1\task1677687\3636-1-bg.htm',USER='105057',CD='Feb  6 22:00 2007' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading --></p>
  </td>
  <td width="45%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:45.82%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-KEY INTERNATIONAL, INC.</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="36%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:36.16%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Francis J. Cusick</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:5.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Francis J. Cusick</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="54%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:54.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated: February 6, 2007</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:3.92%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.88%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


 <p align="center" style="font-size:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">3</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\svasudea\07-3636-1\task1677687\3636-1-bg.htm',USER='105057',CD='Feb  6 22:00 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a07-3636_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div>

<p align="right" style="margin:0pt 0pt 12.0pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
99.1</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman"><img width="130" height="96" src="g36361mmi001.gif"></font></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Ontario Court Denies ComnetiX&#146;s Request to Hear
Injunction Application Before<br>
ComnetiX Shareholders Meeting</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Wall, N.J., February 2, 2007&nbsp;-
BIO-key&#174; International, Inc. (OTC Bulletin Board: BKYI) (&#147;BIO-key&#148;) announced
that the Ontario court denied ComnetiX Inc.&#146;s&#160;
(&#147;ComnetiX&#148;) (TSX: CXI) request today to hear an application - to enjoin
BIO-key&#146;s offer to purchase all the issued and outstanding common shares of
ComnetiX for US $1.29 per share - prior to February 8, 2007, being the last day
for consideration of ComnetiX&#146;s proposed plan of arrangement with L-1 Identity
Solutions, Inc. (&#147;L-1&#148;) pursuant to ComnetiX&#146;s arrangement agreement with L-1.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key also wishes to respond to
ComnetiX&#146;s press release issued earlier today in response to BIO-key&#146;s claims
that ComnetiX fundamentally breached its agreement with BIO-key (the &#147;May 2006
Agreement&#148;), which, among other things, contained a provision that BIO-key will
not acquire or make an offer to acquire ComnetiX shares for a period of one
year (the &#147;Standstill Provision&#148;). In particular, ComnetiX stated that BIO-key&#146;s
claims were without merit for the following reasons:</font></p>

<p style="margin:0pt 0pt 12.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">(1)&#160; ComnetiX never agreed to an extension of the 30-day term of the agreement;</font></i></p><p style="margin:0pt 0pt 12.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">(2)&#160;&#160; It is ComnetiX&#146;s position that BIO-key&#146;s claim that on-going discussions &#147;effectively extended&#148; the written agreement is without&#160; foundation; and</font></i></p><p style="margin:0pt 0pt 12.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">(3) ComnetiX did not breach the exclusivity clause of the agreement while it was in effect.</font></i></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key and its legal advisors disagree
with ComnetiX&#146;s legal and factual analysis for the following reasons, among
others:</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1) Although ComnetiX and BIO-key did not
agree in writing to an extension of the 30 day term of the Agreement, the
parties extended the May 2006 Agreement by their conduct which can be
demonstrated by continual negotiations and meetings between senior executives
of BIO-key and ComnetiX from May 2006 until as late as September 12, 2006 in
respect of a business combination between the two companies.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2) As disclosed in the ComnetiX
Circular, it appears that ComnetiX DID breach the exclusivity clause during the
first 30 days when Bernard Crotty and Alan Brousseau of ComnetiX met with
Charlie Carroll, the Chief Executive Officer of Integrated Biometric Technology
LLC (&#147;IBT&#148;) on May 31, 2006, which was acquired by a&#160; predecessor to L-1 in Nashville, Tennessee.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3) ComnetiX did not raise the issue of
the Standstill Provision in the May 2006 Agreement until after L-1 has raised
its offer twice.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In light of the foregoing, BIO-key still
contends that ComnetiX committed a clear and fundamental breach of the May 2006
Agreement when ComnetiX breached its exclusivity obligations to BIO-key under
the May 2006 Agreement in respect of the L-1 transaction. When ComnetiX
committed this fundamental breach of the May 2006 Agreement, the May 2006
Agreement was at an end and BIO-key was no longer bound by the Standstill
Provision.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\Fc\37215452334_P66497CHE_1677689\3636-1-mm.htm',USER='jmsproofassembler',CD='Feb  6 21:55 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As such, BIO-key still intends to proceed
with its offer to acquire all the issued and outstanding common shares of
Comnetix dated January 19, 2007 and give ComnetiX shareholders an opportunity
to consider the BIO-key offer on its merits. BIO-key intends to file and
deliver to ComnetiX shareholders shortly an amendment to its offer to disclose,
among other things, the existence of the May 2006 Agreement and its legal
position that this agreement has been fundamentally breached.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key also announced that it received a
letter today from L-1&#146;s US counsel today advising that it intends to hold
BIO-key liable to L-1 on the grounds that BIO-key&#146;s actions constitute a
tortious interference with L-1&#146;s proposed transaction with ComnetiX.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, BIO-key intends to
vigorously defend any claims made by ComnetiX and L-1, and consider its own
remedies, against ComnetiX and L-1.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key believes its proposed offer to
acquire all the issued and outstanding common shares of ComnetiX is superior to
L-1&#146;s revised proposal as it offers a significantly higher price per ComnetiX
share and allows shareholders of ComnetiX to participate in the long-term
potential of the combined company.&#160; In
addition, BIO-key believes that the price offered by L-1 significantly
undervalues ComnetiX.&#160; Industry
comparables are currently commanding a multiple of 4 to 5 times revenue while
the revised L-1 offer for ComnetiX remains below 2 times revenue. BIO-key
believes that the long-term potential of the combined company should be able to
command a premium in accordance with industry comparables.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key believes a combination of the two
companies will result in a strong company with the industry&#146;s most complete
end-to-end solution offering to the law enforcement market and also enable the
companies to: share and cross-sell more than 3000 customers; and become a
platform company for further business combinations that will uniquely serve the
robust and growing state, provincial and local public safety markets.</font></p>

<p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About
BIO-key</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key develops and delivers advanced
identification solutions and information services to law enforcement
departments, public safety agencies, and government and private sector
customers. BIO-key mobile wireless technology provides first responders with
critical, reliable, real-time data and images from local, state and national
databases. The company&#146;s high-performance, scalable, cost-effective and
easy-to-deploy biometric finger identification technology accurately identifies
and authenticates users of wireless and enterprise data to improve security,
convenience and privacy and to reduce identity theft. Over 2,500 police, fire
and emergency services departments in North America use BIO-key solutions,
making BIO-key the leading supplier of mobile and wireless solutions for public
safety worldwide. (http://www.bio-key.com)</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">U.S. Regulatory Information</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This exchange offer is
made for the securities of a foreign company.&#160;
The offer is subject to disclosure requirements of a foreign country
that are different from those of the United States.&#160; Financial statements included in the
documents relating to this offer have been prepared in accordance with foreign
accounting standards and therefore may not be comparable to the financial
statements of the registrant which have been prepared in accordance with
generally accepted accounting principles in effect in the United States.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\Fc\37215452334_P66497CHE_1677689\3636-1-mm.htm',USER='jmsproofassembler',CD='Feb  6 21:55 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This
press release is neither an offer to purchase nor a solicitation of an offer to
sell securities.&nbsp; In connection with the proposed transaction, a
registration statement on Form S-4 is expected to be filed with the SEC by
BIO-key unless an exemption from the registration requirements of the Securities
Act of 1933 is applicable.&nbsp; STOCKHOLDERS OF COMNETIX ARE ENCOURAGED TO
READ THE REGISTRATION STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE
SEC IF AND WHEN THEY ARE FILED BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION
ABOUT THE PROPOSED TRANSACTION.&nbsp; All interested persons may obtain a free
copy of the registration statement and any other related documents on the SEC&#146;s
website at www.sec.gov.&nbsp; Such documents may also be obtained for free from
BIO-key.</font></p>

<p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key
Safe Harbor Statement</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This news release contains
forward-looking statements that are subject to certain risks and uncertainties
that may cause actual results to differ materially from those projected on the
basis of these statements. The words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148; &#147;expects,&#148;
&#147;believes,&#148; and similar expressions are intended to identify forward-looking
statements. Forward-looking statements in this press release include all
statements related to the results of the proposed exchange offer and the
expected results of combining BIO-key and ComnetiX. Such forward-looking
statements are made based on management&#146;s beliefs, as well as assumptions made
by, and information currently available to, management pursuant to the &#147;safe-harbor&#148;
provisions of the Private Securities Litigation Reform Act of 1995. For a more
complete description of these and other risk factors that may affect the future
performance of BIO-key International, see &#147;Risk Factors&#148; in the Company&#146;s
Annual Report on Form 10-KSB and its other filings with the Securities and
Exchange Commission. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date made. The Company
also undertakes no obligation to disclose any revision to these forward-looking
statements to reflect events or circumstances after the date made or to reflect
the occurrence of unanticipated events.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Press Contact</font></u></b>:</p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Julie Garand</font></p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">508-460-4036</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">julie.garand@bio-key.com</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Investor Contact</font></u>:</b></p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gus Okwu</font></p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dennard Rupp Gray &amp; Easterly, LLC</font></p>

<p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">713-529-6600</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">gokwu@drg-e.com</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\Fc\37215452334_P66497CHE_1677689\3636-1-mm.htm',USER='jmsproofassembler',CD='Feb  6 21:55 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g36361mmi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g36361mmi001.gif
M1TE&.#EA@@!@`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y
M!`$`````+`````"!`%\`AP``````````,P``9@``F0``S```_P`S```S,P`S
M9@`SF0`SS``S_P!F``!F,P!F9@!FF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9
M_P#,``#,,P#,9@#,F0#,S`#,_P#_``#_,P#_9@#_F0#_S`#__S,``#,`,S,`
M9C,`F3,`S#,`_S,S`#,S,S,S9C,SF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F
M_S.9`#.9,S.99C.9F3.9S#.9_S/,`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_
M9C/_F3/_S#/__V8``&8`,V8`9F8`F68`S&8`_V8S`&8S,V8S9F8SF68SS&8S
M_V9F`&9F,V9F9F9FF69FS&9F_V:9`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,
M9F;,F6;,S&;,_V;_`&;_,V;_9F;_F6;_S&;__YD``)D`,YD`9ID`F9D`S)D`
M_YDS`)DS,YDS9IDSF9DSS)DS_YEF`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF9
M9IF9F9F9S)F9_YG,`)G,,YG,9IG,F9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G_
M_\P``,P`,\P`9LP`F<P`S,P`_\PS`,PS,\PS9LPSF<PSS,PS_\QF`,QF,\QF
M9LQFF<QFS,QF_\R9`,R9,\R99LR9F<R9S,R9_\S,`,S,,\S,9LS,F<S,S,S,
M_\S_`,S_,\S_9LS_F<S_S,S___\``/\`,_\`9O\`F?\`S/\`__\S`/\S,_\S
M9O\SF?\SS/\S__]F`/]F,_]F9O]FF?]FS/]F__^9`/^9,_^99O^9F?^9S/^9
M___,`/_,,__,9O_,F?_,S/_,____`/__,___9O__F?__S/___P$"`P$"`P$"
M`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"
M`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"
M`P$"`P$"`P$"`P$"`P$"`P$"`PC_`+$)'$BPH,&#"!,J''AMH<.'$"-*G$BQ
MHL6+&`NV.KC18$>-`VD-=,7QFBEHGY2E7*G,5+1H"45ZY$ASIDV0-S-*-/F)
M#ITV0(,*'0K4YR>7#74J73I1)K96INA@:C.GS26K;:9>U9H5*]>K5>?,*66*
MJ=FS!UE]JDIUSM6W;<%B%0M6;-RY08^B9?J18-^!'V$*)"FP5:DVD;PJWMKU
M*U:X<*=*[GKU$RML3O\6KHFSL]^]`UG]O%L5,EZ@58U^*D66]:>>HX.*I8NZ
M+.C;!),.+/63\63&<.?0,67JFFZ'T:Z56AO9:ZF!@G&#-A6TKG6J08<?SQAM
MS\_$8A-?_Y8N4?/3@;,&1E7,]7<2O9]S`N8LT/OC-IY@FM]/?[Y\BGJ@-I==
M<LUA&WD"13,:6P<BB%$TBU'651MT1.<@8)]@12%#%TX4X%MNW064'N9U*%"&
MB+5AH8/\;=;*3Y/%:%42@GUD8W^;W:3;1^D))%(KGF#58&`XGO=?1-3A%19V
M;3QG(D34)?;)DPB)M$=SP+7QR49.X;:=0%]BHQL=54U)I4%[4'4=;0V>"1&*
M9G;((S9T^-885M=D5F2+!3EEBEJ\?;('<2N*Z1\V2<;IV:'Q+8I0@-@M&1X=
M#D;%%E%"S;'E0JT`U2:"5E;UVX24=LF43`J6=A\FFM+1TU1!)?]1W$$_5E4H
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MV6S//%":D4I-M4""L!#`W7@'P$)?K5S_P8+??O^-4-UVYWU%V`K5'8!Y+AW4
M,UI"3Y9QWI3GS<)`5U1^]Q4%%:XYWA-ECK<@".UQT&MGD;MK&Y=I_K?GH#\E
M.MZ"`_:YYJ0_)`CEG!^T[]=*U0DM5@+!'D#NQ1L^T.YX\\V[C;/?C;S,T>?^
MT8_3=D1'F#&G;'.D36*>MT&4B]\\091/;_OX$,W>>T1[.&T1>UA%\E'T!D7?
M$?-W?U2XW>\S"/_NUK[1320:99G81-)TG38T2'\%P9]`(/B4\BF$<HB;(-X"
M^)!HL$PGU^C-7$RW&0D2!';+RUM'HL<Y_K`0(7V9G?5D%AT2NBV#!F&%)S#A
MJD*9<"#*T^#Y_["!04Y9<"'N<Y-$3-B*`0:`(`/L2!$7,D6%R!`;=0,<"]3G
MQ,-A48M^RYT@P$BZ*XR1(OIS70156$'V49&-2-P@$2N'OL\ICH[8,-X6F]BW
M/6&C>K@K2!2Q:+G_P`YY);KB'#?7D598;HQY$\0`]U88_G%.DF94GT/P%[C*
MW8^-CG2C0@ZY23DNLB^>NQS=QI?$.JK2C%\,G2C_>,1!AO)NJEP(*>,HO45.
M[Y:+2R'H@`G%7D[PC+*,'4%>2,OS`?.)#L%@*^S&@FKJK9J<<U_AU,?$('KN
M?<J$87]^"$3V#7*1_;MA&T'GQ/)%3YD=^6;R#%@8]H5RAA<AIT`L2/_!72;D
MF<W\7$"#6$[I3=(@GBLC`96B3W1"\YP''64DCVG&BHYQ(^^DYSP#,#M*"G!\
MN"Q(C]`XRWVRCX(.?6,XK3BZ'W[3;IJL(R[3&1$7EC2EA!SB0`.(2H*V+:"D
M*^0J5SHXRN424<LQ!0X[5U+8]0ZE#N6@$(F:$'D"$YP:+6=?TI<@H@!/(<_D
MZ`EK.5&9XA)Y&5TB/:NWT>,),YCF6R@V."8A'D;D=IH;*AX+BE>Y.F2:O&LK
M)8T7V(*8,EMR8Y8ZQ]K7]V74F'']'`=;U$ZX&G6J7/5/X3;RJ^$=S5Q@[20N
M82E(29I6$"7J6RJ]2)'3FA:*KX5B-?\64Y/_0A-JX`.+$G=;$7HF06AOL2%O
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MKGB3!4PK.`L4&5WE_ZL5@3%\Y4K@$^^3=':;(.=2[,C92ABN<I;BY=H[XCY;
M<R-'7LB2ZL*6\3P8FM`4,XEW2L3<9=AO_"7BAEL(Z(?J+<.T-&FH][EG\R(D
M2,"U"IPMTDA&S6G-K9[/FG/$MUACIDM6/A=Y04+>61_D,+2AS='`.C9.C80C
MT<!AB1`(C9,01YQ'2@BY9"29<+GM+'2P=NFHXNB(L`)20B%81CJU+O!]4#K1
MF(/2P)KM2]`!&O(3B"D.TV8AX<RS73G;A9*D0&R(1C:8T,-KE@.;ZF#'5;B)
M$I/ALNJV=6]:W2+)'B*Q[FDIV$?%2E**3",7GPC&*=%Y^$<N+N_A369[U_^6
M#J3BG1O#P,8G=-"#'LCB(*L]1FYSZ#=YA"=NXA8&O5F:2H6&2R;\^#PA25J7
MW%!>GB=W1C<BH4-BZ'`9T(K<Z8T::;M,WA4SW6JI9T&1EHY^7$;?IRKGYJU(
M.JMN9:@=&WM05:HOH6VR)^@G8>FYKPP>[!!MB")7#QET_'.8M\AJ11_9$6=(
M/B<TB8KK;\;72)?KIG0+B$+=GDYLHK9H\`G7[@HIQ>-30W66']`^6!K>WT$?
MD0R!QRX4.HKI$<(*2PUH5U<!BB?`#I'`HRMF/8F07#RQLE(T&X$(K+TI!"X<
M@U/[3F!A.LA^S_KU#$A2F,H4:1B\?:KHG?7E`79EUU)-?NA+".V\![]$$#B:
MUR\9]PZ[E'`:AYL;Z?I0]L\>_O>O(^6L!5CWP7%SD01D\@F!<'%.,7WYMX`R
KHWX&82QD\1H2.(&L07\.>($8F($:N($ZQR$;^($@&((B.((D6((5$1``.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
